163 related articles for article (PubMed ID: 21172112)
21. Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.
Matsubara N; Mukai H; Naito Y; Nezu M; Itoh K
Asia Pac J Clin Oncol; 2013 Dec; 9(4):310-7. PubMed ID: 23127231
[TBL] [Abstract][Full Text] [Related]
22. Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.
Yeshchina O; Badalato GM; Wosnitzer MS; Hruby G; RoyChoudhury A; Benson MC; Petrylak DP; McKiernan JM
Urology; 2012 Feb; 79(2):384-90. PubMed ID: 22196406
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.
Kaimakliotis HZ; Monn MF; Cho JS; Pedrosa JA; Hahn NM; Albany C; Gellhaus PT; Cary KC; Masterson TA; Foster RS; Bihrle R; Cheng L; Koch MO
Future Oncol; 2016 Aug; 12(15):1795-804. PubMed ID: 27255805
[TBL] [Abstract][Full Text] [Related]
24. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.
Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1992 Aug; 148(2 Pt 1):302-6; discussion 306-7. PubMed ID: 1635123
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.
Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986
[TBL] [Abstract][Full Text] [Related]
26. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
[TBL] [Abstract][Full Text] [Related]
28. The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.
Jeong H; Park KJ; Lee Y; Kim HD; Kim JH; Yoon S; Hong B; Lee JL
Cancer Res Treat; 2022 Jan; 54(1):226-233. PubMed ID: 33957019
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
30. Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Krabbe LM; Westerman ME; Margulis V; Raj GV; Sagalowsky AI; Courtney K; Arriaga Y; Lotan Y
Can J Urol; 2015 Aug; 22(4):7865-75. PubMed ID: 26267024
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.
Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y
Med Oncol; 2014 May; 31(5):949. PubMed ID: 24700028
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
35. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
Chen J; Miranda G; Cai J; Daneshmand S; Djaladat H
Scand J Urol; 2019; 53(2-3):123-128. PubMed ID: 31081431
[No Abstract] [Full Text] [Related]
36. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.
Sonpavde G; Goldman BH; Speights VO; Lerner SP; Wood DP; Vogelzang NJ; Trump DL; Natale RB; Grossman HB; Crawford ED
Cancer; 2009 Sep; 115(18):4104-9. PubMed ID: 19517476
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R
BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762
[TBL] [Abstract][Full Text] [Related]
38. [Modern chemotherapy of invasive bladder cancer].
Géczi L
Magy Onkol; 2007; 51(2):133-8. PubMed ID: 17660869
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
Dorff TB; Tsao-Wei D; Miranda G; Skinner DG; Stein JP; Quinn DI
World J Urol; 2009 Feb; 27(1):39-44. PubMed ID: 19020886
[TBL] [Abstract][Full Text] [Related]
40. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
Lee EK; Herr HW; Dickstein RJ; Kassouf W; Munsell MF; Grossman HB; Dinney CP; Kamat AM
BJU Int; 2012 Dec; 110(11 Pt B):E590-5. PubMed ID: 22758775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
